Rare germline variant contributions to myeloid malignancy susceptibility.
Li ST, Wang J, Wei R, Shi R, Adema V, Nagata Y, Kerr CM, Kuzmanovic T, Przychodzen B, Sole F, Maciejewski JP, LaFramboise T.
Li ST, et al. Among authors: laframboise t.
Leukemia. 2020 Jun;34(6):1675-1678. doi: 10.1038/s41375-019-0701-8. Epub 2020 Jan 7.
Leukemia. 2020.
PMID: 31911633
Free PMC article.
No abstract available.